Back to company

AVILEX PHARMA ApS: Financial statements 2016

CVR: 34896828

AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -5,450,675 compared with DKK -7,570,524 the year before. Equity amounted to DKK -5,729,893. The company had 1 employee in the financial year.

Profit/Loss
-5,450,675 kr.
Equity
-5,729,893 kr.
Total Assets
4,780,280 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016---5.5 mio.-5.7 mio.1
2015---7.6 mio.-279 t.3
2014---1.2 mio.-4.1 mio.0
2013---2.9 mio.-2.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is AVILEX PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

Raymond George Hill joins the board of AVILEX PHARMA ApSMay 20, 2016

As of May 20, 2016, Raymond George Hill has joined the board of directors of AVILEX PHARMA ApS.

Emmanuelle Coutanceau joins the board of AVILEX PHARMA ApSMay 20, 2016

As of May 20, 2016, Emmanuelle Coutanceau has joined the board of directors of AVILEX PHARMA ApS.

AVILEX PHARMA ApS: The 2015 annual report is outMay 19, 2016

AVILEX PHARMA ApS has published its annual report for 2015. The net result was DKK -7,570,524.

Raymond George Hill leaves the board of AVILEX PHARMA ApSMay 19, 2016

As of May 19, 2016, Raymond George Hill has left the board of directors of AVILEX PHARMA ApS.

Emmanuelle Coutanceau leaves the board of AVILEX PHARMA ApSMay 19, 2016

As of May 19, 2016, Emmanuelle Coutanceau has left the board of directors of AVILEX PHARMA ApS.

Kristian Strømgaard joins AVILEX PHARMA ApS as directorJan 17, 2016

As of January 17, 2016, Kristian Strømgaard is registered as director of AVILEX PHARMA ApS.

Jonathan Mark Treherne joins AVILEX PHARMA ApS as adm. dir.Jan 17, 2016

As of January 17, 2016, Jonathan Mark Treherne is registered as adm. dir. of AVILEX PHARMA ApS.

Kristian Strømgaard steps down as adm. dir. of AVILEX PHARMA ApSJan 16, 2016

As of January 16, 2016, Kristian Strømgaard has stepped down as adm. dir. of AVILEX PHARMA ApS.

About AVILEX PHARMA ApS

AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees. In 2024, the company reported a net result of DKK -4,428,000 compared with DKK -6,756,000 the year before. Equity amounted to DKK -6,267,000.